Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Gr... ( A Drug That Improves Survival When Ad...)

HOME >> MEDICINE >> NEWS

Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma

Date:3/9/2009

A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme, According to a New Report from Decision Resources

WALTHAM, Mass., March 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed oncologists identify a therapy's effect on overall survival as the attribute that most influences their prescribing decisions in high-grade glioma. Clinical data and the opinions of interviewed thought leaders indicate that Roche/Genentech/Chugai's Avastin has advantages in this attribute over Schering-Plough's Temodar/Temodal (temozolomide), the sales-leading agent in the market.

The new report entitled High-Grade Glioma: Prolonged Survival over Temozolomide Will Be Integral to Market Success finds that a therapy, when added to temozolomide, that increases median overall survival compared with temozolomide alone would earn a 65 percent patient share in the United States and a 30 percent share in Europe in newly diagnosed glioblastoma multiforme, according to surveyed U.S. and European oncologists.

In 2008, Decision Resources' proprietary clinical gold standard for high-grade glioma was Avastin. Although Avastin is not formally approved for the treatment of high-grade glioma, the drug is widely prescribed off-label as a result of promising Phase II clinical trial data. Based on expert opinion, Avastin will retain clinical gold standard status through 2017, owing to its high efficacy.

"Avastin emerges as our gold standard because of its efficacy, the attribute surveyed oncologists rated as the most important in treating high-grade glioma," said Decision Resources Analyst Ramya Kollipara, Ph.D. "Because the prognosis for high-grade glioma patients is so poor, inter
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
4. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
5. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
6. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
7. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
8. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
9. Jefferson radiation oncologists use real-time system to plant seeds against cancer
10. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
11. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer

Post Your Comments:

(Date:3/15/2010)... Joins March for Babies (R) , ... , ... ... ... WHITE PLAINS, N.Y. , March 15 Mission Pharmacal announced today ...

(Date:3/15/2010)... among the first in the nation to offer Ultherapy™ , ... ... the increasing demand for non-surgical aesthetic procedures, FDA’s recent clearance of ... to consumers, especially those in this community, home to one of ... , , ,While drawing on the same reliable ultrasound principles that ...

(Date:3/15/2010)... an obscure Georgia Law that forces insurance companies to cover Sedation ... Dr. Kurtzman has been practicing Dentistry in Georgia for over 20 ... general public knows little or nothing about "Senate Bill 66". ... ... severe gagging, life threatening allergies and the inability to use local ...

(Date:3/15/2010)... Sigma-Aldrich® (Nasdaq: SIAL ) today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 ... ... , , ... ... ...

(Date:3/14/2010)... a company that builds open source platforms ... a two-year grant from the National Institutes ... to focus research efforts on developing approach-specific, ... goal of the research is to work ... neurosurgery cases of young surgeons, enabling hospitals ...

Breaking Medicine News(10 mins):Health News:Mission Pharmacal and March of Dimes Share Commitment to Healthy Babies 2 Health News:Mission Pharmacal and March of Dimes Share Commitment to Healthy Babies 3 Health News:Mission Pharmacal and March of Dimes Share Commitment to Healthy Babies 4 Health News:Medical Ultrasound Now Used in New, Non-surgical Cosmetic Procedure 2 Health News:Georgia Dentist Uncovers Obscure Law That Helps Dental Patients With Severe Anxiety 2 Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 2 Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 3 Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 4 Health News:Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds 5 Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 2 Health News:National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation 3

[0] Mission Pharmacal and March of Dimes Share Commitment to Healthy Babies [1] Medical Ultrasound Now Used in New, Non-surgical Cosmetic Procedure [0] Georgia Dentist Uncovers Obscure Law That Helps Dental Patients With Severe Anxiety [0] Sigma-Aldrich Reaches Agreement to Sell Pfizer's Bioactive Small Molecule Compounds [0] National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation

... MacroGenics Inc, a private,biotechnology company focused on ... cancers, and infectious diseases, today announced the,appointments ... President and,Chief Commercial Officer and Mr. James ... "We are very fortunate to attract two ...

... May 6 This spring graduation season,Park Road Books ... Hospital to raise money for the Children,s Fund. Two-thirds ... includes Author Anna,Quindlen,s commencement address, "A Short Guide to ... a Short Life, A Response to Ms.,Quindlen,s Fine Book," ...

... (FTSE: MSY.L), the,global application software and services company, today ... been selected by Masraf Al,Rayan to build a true ... was chosen as the best partner for Masraf Al ... proven expertise in Islamic,finance and credibility in the region., ...

... their first year of entering, SRG were,winners in two ... are the biggest, most comprehensive and most prestigious,covering the ... were,for Best Candidate Care and Best Health Care/Medical Recruitment ... Award stated that SRG had,demonstrated that caring for its ...

... May 5 Customer Communications Group, Inc.,(CCG), a ... to provide direct marketing assistance to The Children,s ... pediatric,healthcare. CCG is a 30-year pioneer in the ... an industry leader in direct marketing,innovation., Sandra ...

... of Veterans, WASHINGTON, May 5 After a ... decided it,will continue to provide services at its four ... "The potential benefits to be gained from any ... our first-class health care system,in Boston," said Secretary of ...

Other Medicine News:Health News:MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer 2 Health News:MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer 3 Health News:MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer 4 Health News:Graduation Gift Books to Benefit Levine Children's Hospital 2 Health News:Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations 2 Health News:Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations 3 Health News:SRG Scoops Two Recruiter Awards for Excellence 2 Health News:Customer Communications Group Selected by The Children's Hospital for Direct Marketing Expertise 2 Health News:VA Retains Facilities at Four Boston Campuses 2

MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer Graduation Gift Books to Benefit Levine Children's Hospital Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations SRG Scoops Two Recruiter Awards for Excellence Customer Communications Group Selected by The Children's Hospital for Direct Marketing Expertise VA Retains Facilities at Four Boston Campuses

(Date:3/12/2010)... primary and metastatic cancers to the liver, today provided an update on recent corporate developments. , ... , , ... ... ... ...

(Date:3/11/2010)... Zimmer Holdings, Inc. (NYSE: ... care, will celebrate the 25th anniversary of the ... this year. The Natural Knee ... anatomically designed implants used in more than 400,000 ... the Natural Knee system to be ...

(Date:3/11/2010)... March 11 Watson Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) approval of ... a new twice-yearly formulation of TRELSTAR®, a proven, ... cancer. With an anticipated May launch, TRELSTAR® 22.5 ... (IM) GnRH agonist available for the palliative treatment ...

[0] Delcath Systems Provides Update on Corporate Developments [0] Zimmer Natural Knee Celebrates 25 Years of Excellence [0] FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer

... who received,OrbusNeich,s pro-healing stent, the Genous Bio-engineered R ... than patients who,received Boston Scientific,s TAXUS or Johnson ... at Federico II University of,Naples in Naples, Italy. ... the XXVIII National Congress of the Italian Society ...

... Age, Becomes Squarer, Makes You Look Older, ASPS,Study Reveals, ... be giving away your age, and it has nothing ... study in January,s Plastic and,Reconstructive Surgery(R) (PRS), the official ... found that as we age, the,lower jaw continues to ...

Other Medicine Technology:OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial 2 Looking Older? How Square is Your Jaw Line? 2

OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial Looking Older? How Square is Your Jaw Line?

... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...

... of plugs and allow precise control of liquid ... sorting. Colored graduations are enameled onto the glass. ... "To Deliver" its total capacity when the last ... L 8 350 mm Measur range: volume ...

Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...

... and O.R. staff work hard to protect ... intravasation. Manual methods are complicated, time-consuming, and ... II Fluid Management System for hysteroscopy, designed ... irrigation. It has been developed to provide ...

Medicine Products:

CORNING STRIPETTE SEROLOGICAL PIPETTE, 50 ml Pyrex brand reusable serological pipet, color-coded, for cotton plugging Pyrex brand serological disposable pipettes, sterile, multi-pack DOLPHIN® II Hysteroscopic Fluid Management System

Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Gr...( A Drug That Improves Survival When Ad...),Health